Rare Cancer News & Clinical Trials » Trial - Sarcoma

Feeds

40322 items (40322 unread) in 74 feeds

Acinar Cell Carcinoma (947 unread)

• Google - Acinar Cell Carcinoma (826 unread)
• PubMed - Acinar Cell Carcinoma (112 unread)
• Trial - Acinar Cell Carcinoma (9 unread)

Acinic Cell Carcinoma (353 unread)

• Google - Acinic Cell Carcinoma (212 unread)
• PubMed - Acinic Cell Carcinoma (141 unread)
• Trial - Acinic Cell Carcinoma

Adenoid Cystic Carcinoma (509 unread)

• Google - Adenoid Cystic Carcinoma (483 unread)
• PubMed - Adenoid Cystic Carcinoma (4 unread)
• Trial - Adenoid Cystic Carcinoma (22 unread)

Adrenal Gland Cancer (3507 unread)

• Google - Adrenal Cancer (1769 unread)
• Google - Adrenocortical Carcinoma (665 unread)
• PubMed - Adrenal Cancer (695 unread)
• PubMed - Adrenocortical Carcinoma (195 unread)
• Trial - Adrenal Cancer (139 unread)
• Trial - Adrenocortical Carcinoma (44 unread)

Ampulla Of Vater (575 unread)

• Google - Ampullary Cancer (464 unread)
• PubMed - Ampullary Cancer (102 unread)
• Trial - Ampullary Carcinoma (9 unread)

Anal Cancer (3208 unread)

• Google - Anal Cancer (1567 unread)
• PubMed - Anal Cancer (1485 unread)
• Trial - Anal Cancers (156 unread)

Angiosarcoma (1004 unread)

• Google - Angiosarcoma (634 unread)
• PubMed - Angiosarcoma (348 unread)
• Trial - Angiosarcoma (22 unread)

Appendix Cancer (1264 unread)

• Google - Appendix Cancer (948 unread)
• PubMed - Appendix Cancer (235 unread)
• Trial - Appendix Cancer (81 unread)

Bile Duct Cancer (5441 unread)

• Google - Bile Duct Cancer (1583 unread)
• Google - Cholangiocarcinoma (1264 unread)
• PubMed - Bile Duct Cancer (657 unread)
• PubMed - Cholangiocarcinoma (1454 unread)
• Trial - Bile Duct Cancer (264 unread)
• Trial - Cholangiocarcinoma (219 unread)

Brain and CNS (7735 unread)

• Google - Rare Brain Tumor (2323 unread)
• Google - Rare CNS Tumor (1892 unread)
• PubMed - Ganglioglioma (52 unread)
• PubMed - Rare Brain Tumor (678 unread)
• PubMed - Rare CNS Tumor (423 unread)
• Trial - Brain Tumor (1235 unread)
• Trial - CNS Tumor (1126 unread)
• Trial - Ganglioglioma (6 unread)

Carcinoid (859 unread)

• Google - Carcinoid (570 unread)
• PubMed - Carcinoid (281 unread)
• Trials - Carcinoid (8 unread)

Endocrine/Neuroendocrine (6661 unread)

• Google - Merkel Cell Cancer (983 unread)
• Google - Neuroendocrine Tumor (1451 unread)
• PubMed - Merkel Cell Cancer (202 unread)
• PubMed - Neuroendocrine Tumor (3249 unread)
• Trial - Merkel Cell Cancer (54 unread)
• Trial - Neuroendocrine Cancers (722 unread)

Gall Bladder Cancer (1824 unread)

• Google - Gall Bladder Cancer (1458 unread)
• PubMed - Gall Bladder Cancer (289 unread)
• Trials - Gall Bladder Cancer (77 unread)

Hemangioendothelioma (1750 unread)

• Google - Hemangioendothelioma (884 unread)
• PubMed - Hemangioendothelioma (856 unread)
• Trial - Hemangioendothelioma (10 unread)

Hepatoblastoma (545 unread)

• Google - Hepatoblastoma (342 unread)
• PubMed - Hepatoblastoma (178 unread)
• Trial - Hepatoblastoma (25 unread)

Pancreas (607 unread)

• Google - Insulinoma (408 unread)
• PubMed - Insulinoma (192 unread)
• Trial - Insulinoma (7 unread)

Phyllodes (491 unread)

• Google - Phyllodes Tumor (391 unread)
• PubMed - Phyllodes Tumor (100 unread)
• Trial - Phyllodes

PMP and Mucinous Tumors (396 unread)

• Google - Pseudomyxoma Peritonei (308 unread)
• PubMed - Pseudomyxoma Peritonei (PMP) (79 unread)
• Trial - Pseudomyxoma Peritonei (9 unread)

Rhabdomyosarcoma (1282 unread)

• "rhabdomyosarcoma" - Google News (806 unread)
• PubMed - Rhabdomyosarcoma (410 unread)
• Trial - Rhabdomyosarcoma (66 unread)

Sarcoma (1364 unread)

• "sarcoma" - Google News (801 unread)
• PubMed - Sarcoma (538 unread)
• Trial - Sarcoma (25 unread)

Trial - Sarcoma (25 unread)

• 

  Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

  Posted: September 22nd, 2023, 2:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:  
  Sponsors:   Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest;   PharmaMar
  Not yet recruiting
• 

  Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

  Posted: September 6th, 2023, 2:00pm GMT

  Condition:   Retroperitoneal Sarcoma
  Interventions:   Drug: Abemaciclib;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Radiation: Radiation Therapy;   Procedure: Therapeutic Surgical Procedure
  Sponsors:   University of Washington;   Eli Lilly and Company
  Not yet recruiting
• 

  A Study to Evaluate Pre- or Post-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

  Posted: September 1st, 2023, 2:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Interventions:   Procedure: Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.;   Procedure: Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
  Sponsor:   Institut Claudius Regaud
  Not yet recruiting
• 

  To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)

  Posted: August 1st, 2023, 2:00pm GMT

  Condition:   Ewing Sarcoma
  Intervention:   Drug: Naxitamab
  Sponsors:   Anna Raciborska;   Wroclaw Medical University
  Not yet recruiting
• 

  Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

  Posted: July 19th, 2023, 2:00pm GMT

  Condition:   Sarcoma
  Intervention:   Drug: Fluzoparib+ Dalpiciclib
  Sponsors:   Sun Yat-sen University;   Jiangsu Hengrui Pharmaceutical Co., Ltd.
  Recruiting
• 

  Multicenter, Open-label, Phase I/II Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas.

  Posted: July 19th, 2023, 2:00pm GMT

  Condition:   Malignant Sarcoma
  Intervention:   Other: Natural Killer (NK) cells (a new immunotherapy)
  Sponsor:   Antonio Pérez Martínez
  Recruiting
• 

  IVIM & OLINK in Sarcoma

  Posted: July 18th, 2023, 2:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Interventions:   Radiation: Radiotherapy;   Other: Surgery
  Sponsor:   University Health Network, Toronto
  Not yet recruiting
• 

  Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma

  Posted: July 10th, 2023, 2:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Interventions:   Drug: Fluzoparib;   Radiation: Preoperative moderately fractionated radiotherapay
  Sponsors:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Beijing Jishuitan Hospital
  Recruiting
• 

  Synovial Sarcoma Registry / Biospecimen Repository

  Posted: June 19th, 2023, 2:00pm GMT

  Condition:   Synovial Sarcoma
  Intervention:  
  Sponsor:   Children's Hospital of Philadelphia
  Recruiting
• 

  Molecular Mechanism Study of Uterine Sarcoma

  Posted: May 31st, 2023, 2:00pm GMT

  Condition:   Uterine Sarcoma
  Intervention:   Diagnostic Test: Diagnostic biomarker
  Sponsor:   Shixuan Wang
  Recruiting
• 

  A Study of XmAb23104 in People With Sarcoma

  Posted: May 29th, 2023, 2:00pm GMT

  Condition:   Sarcoma
  Intervention:   Biological: XmAb23104
  Sponsors:   Memorial Sloan Kettering Cancer Center;   Xencor, Inc.
  Recruiting
• 

  Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

  Posted: May 15th, 2023, 2:00pm GMT

  Condition:   Sarcoma, Soft Tissue
  Intervention:   Drug: DPPG2-TSL-DOX
  Sponsor:   Thermosome GmbH
  Recruiting
• 

  Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma

  Posted: May 4th, 2023, 2:00pm GMT

  Condition:   Retroperitoneal Sarcoma
  Interventions:   Drug: Doxorubicin+Ifosfamide+Anlotinib(AI+A);   Procedure: Radical Surgery
  Sponsors:   Peking University International Hospital;   Shanghai Zhongshan Hospital;   The Affiliated Hospital of Qingdao University;   Peking University First Hospital;   Shanghai Cancer Hospital, China;   First Affiliated Hospital Xi'an Jiaotong University;   Beijing Friendship Hospital
  Enrolling by invitation
• 

  A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

  Posted: April 28th, 2023, 2:00pm GMT

  Conditions:   Metastatic Sarcoma;   Sarcoma
  Interventions:   Behavioral: Assessment;   Other: Questionnaire Administration;   Other: Interview;   Other: Electronic Health Record Review
  Sponsor:   Fred Hutchinson Cancer Center
  Not yet recruiting
• 

  Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

  Posted: April 20th, 2023, 2:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:   Combination Product: SBRT + MEDI5752
  Sponsors:   Institut Claudius Regaud;   National Cancer Institute, France;   AstraZeneca
  Not yet recruiting
• 

  Randomized Phase I/II Trial of LB-100 Plus Doxorubicin vs Doxorubicin Alone of Advanced Soft Tissue Sarcomas

  Posted: April 12th, 2023, 2:00pm GMT

  Condition:   Advanced Soft-tissue Sarcoma
  Interventions:   Drug: LB-100 plus Doxorrubicin;   Drug: Doxorubicin
  Sponsor:   Grupo Espanol de Investigacion en Sarcomas
  Recruiting
• 

  A Study of Propranolol to Treat Kaposi Sarcoma

  Posted: April 4th, 2023, 2:00pm GMT

  Condition:   Kaposi Sarcoma
  Intervention:   Drug: Propranolol
  Sponsors:   AIDS Malignancy Consortium;   National Cancer Institute (NCI)
  Not yet recruiting
• 

  Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

  Posted: March 22nd, 2023, 2:00pm GMT

  Condition:   Pediatric Soft Tissue Sarcoma
  Intervention:   Genetic: detection and monitoring of cirulating tumor DNA
  Sponsors:   Sun Yat-sen University;   Nanjing Geneseeq Technology Inc.
  Recruiting
• 

  Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma

  Posted: March 20th, 2023, 2:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:   Radiation: Hypofractionated Radiation Therapy
  Sponsor:   Medical University of South Carolina
  Recruiting
• 

  Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT)

  Posted: March 9th, 2023, 3:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:   Radiation: RT
  Sponsor:   Azienda Ospedaliero-Universitaria Careggi
  Recruiting
• 

  A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

  Posted: March 6th, 2023, 3:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:   Drug: Tigilanol Tiglate
  Sponsor:   QBiotics Group Limited
  Recruiting
• 

  Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

  Posted: February 28th, 2023, 3:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:   Drug: Anrotinib hydrochloride combined with adriamycin
  Sponsor:   Henan Cancer Hospital
  Recruiting
• 

  Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma

  Posted: February 8th, 2023, 3:00pm GMT

  Condition:   Soft Tissue Sarcoma
  Intervention:   Drug: Piamprimab (AK105)
  Sponsor:   Henan Cancer Hospital
  Recruiting
• 

  Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)

  Posted: June 7th, 2018, 2:00pm GMT

  Conditions:   Sarcoma;   Radiosurgery
  Interventions:   Drug: Atezolizumab;   Radiation: SBRT
  Sponsors:   Centre Antoine Lacassagne;   Centre Hospitalier Universitaire de Caen;   Roche Pharma AG
  Recruiting
• 

  CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.

  Posted: June 3rd, 2016, 2:00pm GMT

  Condition:   Soft-tissue Sarcomas
  Intervention:   Other: Procedure/Surgery
  Sponsors:   Institut Bergonié;   National Cancer Institute, France;   Ministry of Health, France
  Recruiting